Skip to content

Dr. Hanne Geerts

Active Private limited companyfounded 2020active for 6 yearsKoning Boudewijnlaan 8, 8310 BrugesKBO/BCE: BE 0755.891.405

Lifetime

6 annual accounts with figures on one time axis
peak of €156,764 in 2024
€131,687▼ 16.0%
peak of €114,755 in 2024
€101,950▼ 11.2%
peak of €175,783 in 2022
€143,434▲ 18.1%
€2,261▼ 89.3%
Board1 name since 2020
1 director
Documentsfilings and deeds
30-08-202630 days late
2025micro format
Gross margin from €156,764 to €131,687Dividend €80,000Equity from €121,484 to €143,434Debts from €21,061 to €2,261

Key points

from the 2025 annual accounts

Equity

€143,434 ▲ 18.1%
121,4842024+101,950Profit-80,000Dividend143,4342025

Dr. Hanne Geerts paid out €80,000 in dividends. That is 78% of the 2025 profit.

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Liquidity

62.96 was 6.56 in 2024

Short-term debts fell from €21,061 to €2,261.

Filings

6 annual accounts 6 late
AprilJune31 JulyOctober202020222024

The 2023 accounts came in latest, 130 days after the end of the period.

Position in the sector

98.4%

Higher solvency than 95% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as Dr. Hanne Geerts has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for Dr. Hanne Geerts. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-10-2020
  • 60 sharesdeed of 12-10-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0755891405
Incorporation Founding capital of €6,000, 60 shares · Founded by · appointed as director · published on 12-10-2020 · Gazette deed
First establishment Koning Boudewijnlaan 8, Bruges
All 14 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Hanne Geerts Bruges €145,695 €131,687 98.4% -
Dr. Veerle Vanlerberghe Beernem €157,622 €133,390 1.1% -
Neurologie Dr. J. Abramski Genk €148,549 €127,740 50.3% -
DERMO MEDICAL CENTER Ixelles €159,586 €130,944 15.0% 3.5
CABINET MEDICAL Adeline VAN RYMENAM Trooz €143,185 €146,080 32.8% -
Dr. Jietse Ryckeboer, Spoedarts Nazareth-De Pinte €137,125 €118,584 1.9% -
Dokter Barbara Sonneville, Geriater Ronse €155,127 €142,414 58.9% -

These companies have the same main activity as Dr. Hanne Geerts: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €137,000 and €160,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 08-10-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.309.194.1738310 Bruges, since 08-10-2020
Financial year end
31 December
Peppol
Reachable since 28-12-2025
Company details

Annual accounts 2025

€145,695▲ 2.2%
Filing
Filed on 30-08-2026
Financials

Insights on Dr. Hanne Geerts

Dr. Hanne Geerts files the micro format. That format states no turnover. The gross margin rose from €43,979 in 2020 to €131,687 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Hanne Geerts

What is the company number of Dr. Hanne Geerts?
The company number of Dr. Hanne Geerts is 0755.891.405. The VAT number is the same number with BE in front: BE 0755.891.405.
Where is Dr. Hanne Geerts based?
The registered office is at Koning Boudewijnlaan 8, 8310 Bruges.Company details
What does Dr. Hanne Geerts do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Hanne Geerts?
Dr. Hanne Geerts is a private limited company (BV).
When was Dr. Hanne Geerts founded?
Dr. Hanne Geerts was founded on 08-10-2020.
Is Dr. Hanne Geerts still active?
Yes, Dr. Hanne Geerts is an active enterprise in the KBO register.
What is the turnover of Dr. Hanne Geerts?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €131,687 and 40 comparable companies (NACE 86220). It probably lies between €210,000 and €330,000.Financials
Is Dr. Hanne Geerts profitable?
In financial year 2025, Dr. Hanne Geerts made a profit of €101,950.
Where can I find the annual accounts of Dr. Hanne Geerts?
Dr. Hanne Geerts filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Hanne Geerts due?
Dr. Hanne Geerts must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.